JOURNAL ARTICLE
RESEARCH SUPPORT, NON-U.S. GOV'T
Add like
Add dislike
Add to saved papers

Pediatric plant exposures in Germany, 1998-2004.

INTRODUCTION: Each year, 80,000 to 100,000 calls to the Poison Information Centres (PIC) concern pediatric exposures in Germany. Plant exposures are the fourth most common category, accounting for 22% of pediatric exposures.

METHODS: Information on plant exposures in children (0-14 years) was collected from annual reports of German PIC. The severity of pediatric plant exposures was classified using the number of ingestions and a calculated hazard factor.

RESULTS: A total of 58,641 cases involving 248 different plant genera were reported from 1998 to 2004. Most plant exposures were not associated with clinical effects at time of call, but 9.6% of cases had noticeable effects, including 0.4% classified as moderate and major effect.

CONCLUSIONS: The majority of plant genera have low hazard factors. Most severe poisoning (highest hazard factors and exposures) in children involved Brugmansia, Laburnum, Phaseolus, and Thuja.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app